FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to compounds of formula (I) wherein A is chosen from -C(=O)NH2 and -C(=S)NH2; both R2 and R2a represent hydrogen atom; R3 is chosen from hydrogen atom and C3-C4cycloalkyl; R4 is chosen from hydrogen atom and hydroxy; R11 represents hydrogen atom; R12 is chosen from hydrogen atom and hydroxy; or radicals R11 and R12 form together a carbonyl substitute; and double bonds marked by dashed lines are absent.
EFFECT: preparation of the drug for treating a opioid receptor mediated disease or condition.
9 cl, 4 tbl, 8 ex
Title | Year | Author | Number |
---|---|---|---|
4-HYDROXYBENZOMORPHAN | 2005 |
|
RU2480455C2 |
TRICYCLIC COMPOUNDS OF BENZOPYRAN AS ANTIARRHYTHMIC AGENTS | 2005 |
|
RU2380370C2 |
SUBSTITUTED CHROMANS | 2015 |
|
RU2718060C2 |
GENERAL SYNTHESIS OF MYRIAPORONES | 2003 |
|
RU2328492C2 |
NOVEL COUMARIN DERIVATIVES WITH ANTI-TUMOUR ACTIVITY | 2007 |
|
RU2428420C2 |
VARIOLINE DERIVATIVES AND THEIR EMPLOYMENT AS ANTITUMOR AGENTS | 2002 |
|
RU2302419C2 |
ECTEINASCEDIN DERIVATIVES, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AND USES THEREOF | 2003 |
|
RU2306316C9 |
2-AMINOBENZOXAZOLE CARBOXAMIDES AS 5-HT3 MODULATORS | 2007 |
|
RU2448105C2 |
AMINE DERIVATIVES AND THEIR USE FOR TREATMENT OF OPHTHALMOLOGICAL DISEASES AND ILLNESSES | 2008 |
|
RU2536040C2 |
NOVEL COMPOUNDS, ISOMERS THEREOF OR PHARMACUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONISTS AND PHARMACEUTICAL COMPOSITION CONTAINING SAID COMPOUNDS | 2007 |
|
RU2448108C2 |
Authors
Dates
2011-03-27—Published
2005-11-03—Filed